Russell-Jones R - Search Results

1

Sentinel node biopsy for malignant melanoma. Staging procedures predict outcome and identify patients needing further treatment.

Russell-Jones R, Calonje E, Healy C, Doherty M, Butler P, Jones A, Whittaker S, Acland K. Russell-Jones R, et al. BMJ. 2000 Nov 18;321(7271):1286-7. BMJ. 2000. PMID: 11082100 No abstract available.

2

Completion lymphadenectomy may not increase in-transit disease in malignant melanoma.

Russell-Jones R, Healy C, Powell AM, Acland K, O'Doherty M, Calonje E. Russell-Jones R, et al. BMJ. 2004 Nov 27;329(7477):1288-9. doi: 10.1136/bmj.329.7477.1288-c. BMJ. 2004. PMID: 15564269 Free PMC article. No abstract available.

3

Staging of melanoma, and the UK guidelines.

Russell-Jones R, Acland K, Calonje E, Doherty M, Healy C. Russell-Jones R, et al. Br J Plast Surg. 2002 Jul;55(5):452-3. doi: 10.1054/bjps.2002.3863. Br J Plast Surg. 2002. PMID: 12372382 No abstract available.

4

Sentinel lymph node biopsy in malignant melanoma.

Healy C, Evans AV, Lister R, O'Doherty M, Calonje E, Acland K, Russell-Jones R. Healy C, et al. Br J Plast Surg. 2001 Apr;54(3):274-5. doi: 10.1054/bjps.2000.3531. Br J Plast Surg. 2001. PMID: 11254432 No abstract available.

5

Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.

Acland KM, Healy C, Calonje E, O'Doherty M, Nunan T, Page C, Higgins E, Russell-Jones R. Acland KM, et al. J Clin Oncol. 2001 May 15;19(10):2674-8. doi: 10.1200/JCO.2001.19.10.2674. J Clin Oncol. 2001. PMID: 11352959

6

Sentinel node biopsy in the management of malignant melanoma.

Russell-Jones R, Acland K. Russell-Jones R, et al. Clin Exp Dermatol. 2001 Sep;26(6):463-8. doi: 10.1046/j.1365-2230.2001.00868.x. Clin Exp Dermatol. 2001. PMID: 11678867 Review.

7

The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).

Russell-Jones R, Powell AM, Acland K, Calonje E, O'Doherty M, Healy C. Russell-Jones R, et al. Eur J Surg Oncol. 2005 Mar;31(2):210-1. doi: 10.1016/j.ejso.2004.10.009. Eur J Surg Oncol. 2005. PMID: 15698741 No abstract available.

8

High-dose interferon and the U.K. guidelines for cutaneous melanoma.

Russell-Jones R, Healy C, Calonje E, Doherty M, Acland K. Russell-Jones R, et al. Br J Dermatol. 2002 Oct;147(4):832-4; author reply 834-5. doi: 10.1046/j.1365-2133.2002.505517.x. Br J Dermatol. 2002. PMID: 12366454 No abstract available.

9

Serum S100 concentrations are not useful in predicting micrometastatic disease in cutaneous malignant melanoma.

Acland K, Evans AV, Abraha H, Healy CM, Roblin P, Calonje E, Orchard G, Higgins E, Sherwood R, Russell-Jones R. Acland K, et al. Br J Dermatol. 2002 May;146(5):832-5. doi: 10.1046/j.1365-2133.2002.04691.x. Br J Dermatol. 2002. PMID: 12000380

10

Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.

Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ. Fraser-Andrews EA, et al. Br J Dermatol. 2006 Oct;155(4):756-62. doi: 10.1111/j.1365-2133.2006.07428.x. Br J Dermatol. 2006. PMID: 16965425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters